Locked nucleic acid oligonucleotides: The next generation of antisense agents?

BioDrugs

Volumn 21, Issue 4, 2007, Pages 235-243

  Grünweller, Arnold ^a   Hartmann, Roland K ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LOCKED NUCLEIC ACID; MICRORNA; NUCLEASE; OLIGONUCLEOTIDE;

ANTISENSE THERAPY; BIODEGRADATION; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DOSE RESPONSE; DRUG UPTAKE; GENE TARGETING; HUMAN; NONHUMAN; NUCLEIC ACID PROBE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; RNA SPLICING; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR;

ANIMALS; HUMANS; MICRORNAS; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES, ANTISENSE; RNA SPLICING; STEREOISOMERISM;

EID: 34250679056     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200721040-00004     Document Type: Review

References (69)

1. Koizuma M. True antisense oligonucleotides with modified nucleotides restricted in the N-conformation. Curr Top Med Chem 2007; 7 (7): 661-5
2. Mouritzen P, Nielsen AT, Pfundheller HM, et al. Single nucleotide polymorphism genotyping using locked nucleic acid (LNA). Expert Rev Mol Diagn 2003 Jan; 3 (1): 27-38
3. Petersen M, Wengel J. LNA: a versatile tool for therapeutics and genomics. Trends Biotechnol 2003 Feb; 21 (2): 74-81
4. Jepsen JS, Wengel J. LNA-antisense rivals siRNA for gene silencing. Curr Opin Drug Discov Devel 2004; 7 (2): 188-94
5. Kauppinen S, Vester B, Wengel J. Locked nucleic acid: high-affinity targeting of complementary RNA for RNomics. Handb Exp Pharmacol 2006; (173): 405-22
6. Koshkin AA, Nielsen P, Meldgaard M, et al. LNA (locked nucleic acid): an RNA mimic forming exceedingly stable LNA. LNA duplexes. J Am Chem Soc 1998; 120: 13252-3
7. Koshkin AA, Singh SK, Nielsen P, et al. LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron 1998; 54: 3607-30
8. Obika S, Nanbu D, Hari Y, et al. Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosides. Tetrahedron Lett 1998; 39: 5401-4
9. Braasch DA, Corey DR. Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem Biol 2001 Jan; 8 (1): 1-7
10. Kurreck J, Wyszko E, Gillen C, et al. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res 2002 May 1; 30 (9): 1911-8
11. Elayadi AN, Braasch DA, Corey DR. Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase. Biochemistry 2002 Aug 6; 41 (31): 9973-81
12. Petersen M, Bondensgaard K, Wengel J, et al. Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA. RNA hybrids. J Am Chem Soc 2002 May 29; 124 (21): 5974-82
13. Petersen M, Nielsen CB, Nielsen KE, et al. The conformations of locked nucleic acids (LNA). J Mol Recognit 2000 Jan-Feb; 13 (1): 44-53
14. Sorensen MD, Kvaerno L, Bryld T, et al. Alpha-L-ribo-configured locked nucleic acid (alpha-L-LNA): synthesis and properties. J Am Chem Soc 2002 Mar 13; 124 (10): 2164-76
15. Crinelli R, Bianchi M, Gentilini L, et al. Design and characterization of decoy oligonucleotides containing locked nucleic acids. Nucleic Acids Res 2002 Jun 1; 30 (11): 2435-43
16. Kumar N, Nielsen KE, Maiti S, et al. Triplex formation with alpha-L-LNA (alpha-L-ribo-configured locked nucleic acid). J Am Chem Soc 2006 Jan 11; 128 (1): 14-5
17. Kurreck J. Antisense technologies: improvement through novel chemical modifications. Eur J Biochem 2003 Apr; 270 (8): 1628-44
18. Wahlestedt C, Salmi P, Good L, et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci U S A 2000 May 9; 97 (10): 5633-8
19. Fluiter K, ten Asbroek AL, de Wissel MB, et al. In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides. Nucleic Acids Res 2003 Feb 1; 31 (3): 953-62
20. Nulf CJ, Corey D. Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs) [published erratum appears in Nucleic Acids Res 2004 Sep 14; 32 (16): 4954]. Nucleic Acids Res 2004 Jul 19; 32 (13): 3792-8
21. Elayadi AN, Demieville A, Wancewicz EV, et al. Inhibition of telomerase by 2′-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells. Nucleic Acids Res 2001 Apr 15; 29 (8): 1683-9
22. Orom UA, Kauppinen S, Lund AH. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 2006 May 10; 372: 137-41
23. Arzumanov A, Walsh AP, Rajwanshi VK, et al. Inhibition of HIV-1 tat-dependent trans activation by steric block chimeric 2′-O-methyl/LNA oligoribonucleotides. Biochemistry 2001 Dec 4; 40 (48): 14645-54
24. Braasch DA, Liu Y, Corey DR. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. Nucleic Acids Res 2002 Dec 1; 30 (23): 5160-7
25. Grunweller A, Wyszko E, Bieber B, et al. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res 2003 Jun 15; 31 (12): 3185-93
26. Simoes-Wust AP, Hopkins-Donaldson S, Sigrist B, et al. A functionally improved locked nucleic acid antisense oligonucleotide inhibits Bcl-2 and Bcl-xL expression and facilitates tumor cell apoptosis. Oligonucleotides 2004; 14 (3): 199-209
27. Hansen JB, Westergaard M, Thrue CA, et al. Antisense knockdown of PKC-alpha using LNA-oligos. Nucleosides Nucleotides Nucleic Acids 2003 May-Aug; 22 (5-8): 1607-9
28. Jepsen JS, Pfundheller HM, Lykkesfeldt AE. Downregulation of p21 (WAF1/CIP1) and estrogen receptor alpha in MCF-7 cells by antisense oligonucleotides containing locked nucleic acid (LNA). Oligonucleotides 2004; 14 (2): 147-56
29. Obika S, Hemamayi R, Masuda T, et al. Inhibition of ICAM-1 gene expression by antisense 2′,4′-BNA oligonucleotides. Nucleic Acids Res Suppl 2001; (1): 145-6
30. Fluiter K, Frieden M, Vreijling J, et al. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide. Chembiochem 2005 Jun; 6 (6): 1104-9
31. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005 Jul 15; 65 (14): 6029-33
32. Vester B, Lundberg LB, Sorensen MD, et al. LNAzymes: incorporation of LNA-type monomers into DNAzymes markedly increases RNA cleavage. J Am Chem Soc 2002 Nov 20; 124 (46): 13682-3
33. Vester B, Hansen LH, Lundberg LB, et al. Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets. BMC Mol Biol 2006 Jun 5; 7: 19
34. Fluiter K, Frieden M, Vreijling J, et al. Evaluation of LNA-modified DNAzymes targeting a single nucleotide polymorphism in the large subunit of RNA polymerase II. Oligonucleotides 2005 Dec; 15 (4): 246-54
35. Fahmy RG, Khachigian LM. Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth. Nucleic Acids Res 2004 Apr 23; 32 (7): 2281-5
36. Schubert S, Gül DC, Grunert HP, et al. RNA cleaving '10-23' DNAzymes with enhanced stability and activity. Nucleic Acids Res 2003 Oct 15; 31 (20): 5982-92
37. Frieden M, Christensen SM, Mikkelsen ND, et al. Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA. Nucleic Acids Res 2003 Nov 1; 31 (21): 6365-72
38. Di Giusto DA, King GC. Strong positional preference in the interaction of LNA oligonucleotides with DNA polymerase and proofreading exonuclease activities: implications for genotyping assays. Nucleic Acids Res 2004 Feb 18; 32 (3): e32
39. Orum H, Jakobsen MH, Koch T, et al. Detection of the factor V Leiden mutation by direct allele-specific hybridization of PCR amplicons to photoimmobilized locked nucleic acids. Clin Chem 1999 Nov; 45 (11): 1898-905
40. Jacobsen N, Fenger M, Bentzen J, et al. Genotyping of the apolipoprotein B R3500Q mutation using immobilized locked nucleic acid capture probes. Clin Chem 2002; 48 (4): 657-60
41. Jacobsen N, Bentzen J, Meldgaard M, et al. LNA-enhanced detection of single nucleotide polymorphisms in the apolipoprotein E. Nucleic Acids Res 2002 Oct 1; 30 (19): e100
42. Kole R, Williams T, Cohen L. RNA modulation, repair and remodeling by splice switching oligonucleotides. Acta Biochim Pol 2004; 51 (2): 373-8
43. Aartsma-Rus A, Kaman WE, Bremmer-Bout M, et al. Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells. Gene Ther 2004 Sep; 11 (18): 1391-8
44. Roberts J, Palma E, Sazani P, et al. Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in mice. Mol Ther 2006 Oct; 14 (4): 471-5
45. Ittig D, Liu S, Renneberg D, et al. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA. Nucleic Acids Res 2004 Jan 15; 32 (1): 346-53
46. Childs JL, Disney MD, Turner DH. Oligonucleotide directed misfolding of RNA inhibits Candida albicans group I intron splicing. Proc Natl Acad Sci U S A 2002 Aug 20; 99 (17): 11091-6
47. Valoczi A, Hornyik C, Varga N, et al. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. Nucleic Acids Res 2004 Dec 14; 32 (22): e175
48. Castoldi M, Schmidt S, Benes V, et al. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA 2006 May; 12 (5): 913-20
49. Wienholds E, Kloosterman WP, Miska E, et al. MicroRNA expression in zebrafish embryonic development. Science 2005 Jul 8; 309 (5732): 310-1
50. Kloosterman WP, Wienholds E, de Bruijn E, et al. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods 2006 Jan; 3 (1): 27-9
51. Nelson PT, Baldwin DA, Kloosterman WP, et al. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA 2006 Feb; 12 (2): 187-91
52. Schubert S, Kurreck J. Oligonucleotide-based antiviral strategies. Handb Exp Pharmacol 2006; (173): 261-87
53. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997 Aug 15; 277 (5328): 955-9
54. Shay JW, Wright WE. Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 2006 Jul; 5 (7): 577-84
55. Christoph T, Gillen C, Mika J, et al. Antinoceptive effect of antisense oligonucleotides against VR1/TRPV1. Neurochem Int 2007 Jan; 50 (1): 281-90
56. Christoph T, Grunweller A, Mika J, et al. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo. Biochem Biophys Res Commun 2006 Nov 10; 350 (1): 238-43
57. Grunweller A, Hartmann RK. RNA interference as a gene-specific approach for molecular medicine. Curr Med Chem 2005; 12 (26): 3143-61
58. Rapozzi V, Cogoi S, Xodo LE. Antisense locked nucleic acids efficiently suppress BCR/ABL and induce cell growth decline and apoptosis in leukemic cells. Mol Cancer Ther 2006 Jul; 5 (7): 1683-92
59. Schubert S, Furste JP, Werk D, et al. Gaining target access for deoxyribozymes. J Mol Biol 2004 May 28; 339 (2): 355-63
60. Charlier TD, Ball GF, Balthazart J. Inhibition of steroid receptor coactivator-1 blocks estrogen and androgen action on male sex behavior and associated brain plasticity. J Neurosci 2005 Jan 26; 25 (4): 906-13
61. Krutzfeldt J, Poy MN, Stoffel M. Strategies to determine the biological function of microRNAs. Nat Genet 2006 Jun; 38 Suppl.: S14-9
62. Esquela-Kerscher A, Slack FJ. Oncomirs: microRNAs with a role in cancer. Nat Rev Cancer 2006 Apr; 6 (4): 259-69
63. Hrdlicka PJ, Babu BR, Sorensen MD, et al. Multilabeled pyrene-functionalized 2′-amino-LNA probes for nucleic acid detection in homogeneous fluorescence assays. J Am Chem Soc 2005 Sep 28; 127 (38): 13293-9
64. Elmen J, Thonberg H, Ljungberg K, et al. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res 2005 Jan 14; 33 (1): 439-47
65. Mouritzen P, Noerholm M, Nielsen PS, et al. ProbeLibrary: a new method for faster design and execution of quantitative real-time PCR. Nature Methods 2005; 2: 313-6
66. Morandi L, Ferrari D, Lombardo C, et al. Monitoring HCV RNA viral load by locked nucleic acid molecular beacons real time PCR. J Virol Methods 2007 Mar; 140 (1-2): 148-54
67. Wang L, Yang CJ, Medley CD, et al. Locked nucleic acid molecular beacons. J Am Chem Soc 2005 Nov 16; 127 (45): 15664-5
68. Frieden M, Orum H. The application of locked nucleic acids in the treatment of cancer. IDrugs 2006 Oct; 9 (10): 706-11
69. Swayze EE, Siwkowski AM, Wancewicz EV, et al. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res 2007; 35 (2): 687-700